Anti-thyroid drug use during the first trimester of pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations

Daniel R. Morales, Lionel Fonkwen, Hedvig M. Nordeng
doi: https://doi.org/10.1101/2020.06.10.20127233

Article usage

Article usage: June 2020 to June 2025

AbstractFullPdf
Jun 2020167035
Jul 202069014
Aug 2020133020
Sep 202034017
Oct 202071015
Nov 202058016
Dec 202017014
Jan 202132314
Feb 202152412
Mar 202153121
Apr 20216653
May 202159217
Jun 20215456
Jul 202128211
Aug 202124513
Sep 202135311
Oct 20214455
Nov 202140214
Dec 202125412
Jan 20222986
Feb 20221415
Mar 20221312
Apr 20221903
May 20221818
Jun 202214111
Jul 20221445
Aug 20221838
Sep 202230013
Oct 202220113
Nov 20222329
Dec 202215212
Jan 20231216
Feb 20231827
Mar 2023909
Apr 202319210
May 2023719
Jun 2023643
Jul 2023804
Aug 202316135
Sep 20231044
Oct 2023805
Nov 2023507
Dec 20231147
Jan 2024811
Feb 2024516
Mar 20241035
Apr 2024554
May 20246453
Jun 2024926
Jul 2024623
Aug 20247312
Sep 2024615
Oct 20241269
Nov 20241019
Dec 20245012
Jan 2025339
Feb 202592719
Mar 2025231912
Apr 20259017
May 202521526
Jun 2025418
Back to top
Posted June 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Anti-thyroid drug use during the first trimester of pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations
Daniel R. Morales, Lionel Fonkwen, Hedvig M. Nordeng
medRxiv 2020.06.10.20127233; doi: https://doi.org/10.1101/2020.06.10.20127233
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area